{"filing":{"accession_number":"0001437749-26-032932","cik":"0000072444","ticker":"VXRT","company_name":"Vaxart, Inc.","form":"8-K","filing_date":"2026-10-19","report_date":"2026-10-16","primary_document":"vxrt20261016_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926032932/vxrt20261016_8k.htm"},"events":[{"id":36071,"run_id":33256,"accession_number":"0001437749-26-032932","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Vaxart appointed Raquel C. Bono, M.D., a retired Vice Admiral and former Director of the Defense Health Agency, to its Board of Directors effective October 16, 2026. Dr. Bono brings extensive healthcare leadership and governance experience and will chair the Stockholder Engagement Committee while serving on the Nominating and Governance Committee and Clinical and Regulatory Affairs Committee.","company_name":"Vaxart, Inc.","ticker":"VXRT","filing_date":"2026-10-19","form":"8-K","submitted_at":null,"items":[{"id":40348,"accession_number":"0001437749-26-032932","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Raquel C. Bono, M.D., to Vaxart's Board of Directors, effective immediately on October 16, 2026, following a Nominating and Governance Committee recommendation. The disclosure emphasizes her extensive qualifications, including her prior role as Director of the Defense Health Agency leading a $50 billion healthcare enterprise, her board service at Humana Inc., and her clinical and public health expertise. The press release notes she was appointed pursuant to a stockholder cooperation agreement and will chair the Stockholder Engagement Committee, making this a material governance event affecting board composition and leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:09:15.622754+00:00","company_name":"","ticker":null,"filing_date":""},{"id":40349,"accession_number":"0001437749-26-032932","item_number":"7.01","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Dr. Raquel C. Bono, a retired Vice Admiral and former Director of the Defense Health Agency, to Vaxart's Board of Directors. The press release emphasizes her extensive leadership, public health, and governance experience, and specifies her committee assignments (Chair of Stockholder Engagement Committee, member of Nominating and Governance Committee and Clinical and Regulatory Affairs Committee). This is a material board appointment that would affect investor assessment of the company's governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:09:15.622754+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":40348,"accession_number":"0001437749-26-032932","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Raquel C. Bono, M.D., to Vaxart's Board of Directors, effective immediately on October 16, 2026, following a Nominating and Governance Committee recommendation. The disclosure emphasizes her extensive qualifications, including her prior role as Director of the Defense Health Agency leading a $50 billion healthcare enterprise, her board service at Humana Inc., and her clinical and public health expertise. The press release notes she was appointed pursuant to a stockholder cooperation agreement and will chair the Stockholder Engagement Committee, making this a material governance event affecting board composition and leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:09:15.622754+00:00","company_name":"Vaxart, Inc.","ticker":"VXRT","filing_date":"2026-10-19"},{"id":40349,"accession_number":"0001437749-26-032932","item_number":"7.01","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Dr. Raquel C. Bono, a retired Vice Admiral and former Director of the Defense Health Agency, to Vaxart's Board of Directors. The press release emphasizes her extensive leadership, public health, and governance experience, and specifies her committee assignments (Chair of Stockholder Engagement Committee, member of Nominating and Governance Committee and Clinical and Regulatory Affairs Committee). This is a material board appointment that would affect investor assessment of the company's governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:09:15.622754+00:00","company_name":"Vaxart, Inc.","ticker":"VXRT","filing_date":"2026-10-19"}]}